Virtuix Holdings Inc. reported financial results for the first quarter of fiscal year 2027 ended June 30, 2026. Net sales decreased 26% to $0.8 million from $1.0 million in the prior-year period, as previous revenue benefited from legacy backlog fulfillment while current sales came from new customers. New orders for Omni One systems increased 72% year-over-year and approximately 150% since the Meta Quest launch. Gross profit rose 29% to $227,158, expanding gross margin to 30% from 17%. The company reported a net loss of $7.2 million, or ($0.22) per share, compared to a $2.3 million loss in the prior year. Operating expenses increased 86% to $4.1 million due to higher stock-based compensation and professional services fees. Cash and cash equivalents totaled $7.4 million at quarter-end. Virtuix Holdings Inc. is a manufacturer of AI-driven, full-body simulation systems for consumer, enterprise, healthcare, and defense markets.

Virtuix Holdings Inc. amended three Class A Common Stock warrants with Streeterville Capital, LLC to reduce the exercise price from $3.00 to $2.50 per share. This price reduction is effective from July 21, 2026, through August 27, 2026, with automatic one-month extensions possible via the Board's Special Committee. Virtuix Holdings Inc. is a technology company providing virtual reality hardware and hardware-integrated software solutions.

On June 29, 2026, Virtuix Holdings Inc. entered into amendments to three existing warrants with Streeterville Capital, LLC. The amendments reduce the exercise price for the Equity Financing Warrant, the Second Debt Financing Warrant, and the Third Debt Financing Warrant from $4.00 to $3.00 per share during a previously established Reduced Exercise Price Period. The expiration date for these warrants remains July 27, 2026. The Company retains the right to terminate the Reduced Exercise Price Period with two trading days' notice, which would revert the exercise price to the Nasdaq Valuation Price. Virtuix Holdings Inc. is a technology company.